Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib | Cell & Bioscience | Full Text
Cancer drug gets a makeover | News | Chemistry World
c‐KIT‐ERK1/2 signaling activated ELK1 and upregulated carcinoembryonic antigen expression to promote colorectal cancer progression - Ma - 2021 - Cancer Science - Wiley Online Library
A decrease in ubiquitination and resulting prolonged life-span of KIT underlies the KIT overexpression-mediated imatinib resistance of KIT mutation-driven canine mast cell tumor cells
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor - ScienceDirect
![PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a2caa75b0240b9cad38286da89c68152befd2d7/11-Figure9-1.png "PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar")
PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar
![Cancers | Free Full-Text | Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance](https://pub.mdpi-res.com/cancers/cancers-15-00143/article_deploy/html/images/cancers-15-00143-g001.png?1672884065 "Cancers | Free Full-Text | Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance")
Cancers | Free Full-Text | Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance
Tyrosine Kinase Inhibitors Induce Down-Regulation of c-Kit by Targeting the ATP Pocket | PLOS ONE
IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
Imatinib - Wikipedia, la enciclopedia libre
The KIT receptor tyrosine kinase. (A) C-KIT mutations occur in 80 –90%... | Download Scientific Diagram
Dysregulation of bone remodeling by imatinib mesylate - ScienceDirect
![PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/52568705464442ace5fec86bca4a1528e3281c4b/70-FigureV-1.png "PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar")
PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review | Biomolecules and Biomedicine
A new monoclonal antibody that blocks dimerisation and inhibits c-kit mutation-driven tumour growth | SpringerLink
Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review
Características genético-moleculares de los tumores estromales gastrointestinales (GIST)
Using Imatinib for Adjuvant Treatment after Resection of Kit-positive GIST - The ASCO Post
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review | Biomolecules and Biomedicine
Mutaciones+del+Gen+c-kit+en+los+GIST | Colectivo Gist España
EPOS™
c-KIT structure, activation and mutations in melanoma. (A) The... | Download Scientific Diagram
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors - ScienceDirect
Axitinib overcomes multiple imatinib resistant cKIT mutations including the gatekeeper mutation T670I in gastrointestinal stromal tumors - Feiyang Liu, Fengming Zou, Cheng Chen, Kailin Yu, Xiaochuan Liu, Shuang Qi, Jiaxin Wu, Chen
c-キッ阻害 | c-Kit Inhibition
Hotspot Mutations in KIT Receptor Differentially Modulate Its Allosterically Coupled Conformational Dynamics: Impact on Activation and Drug Sensitivity | PLOS Computational Biology
